Platelet counts and platelet activation markers in obese subjects

Mediators of Inflammation

Volumn 2008, Issue , 2008, Pages

  Samocha Bonet, Dorit ^a   Justo, Dan ^a   Rogowski, Ori ^a   Saar, Nili ^a   Abu Abeid, Subchi ^a   Shenkerman, Galina ^a   Shapira, Itzhak ^a   Berliner, Shlomo ^a   Tomer, Aaron ^b  

^a TEL AVIV UNIVERSITY   (Israel)

^b BEN GURION UNIVERSITY OF THE NEGEV   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; C REACTIVE PROTEIN; FIBRINOGEN RECEPTOR; LIPOCORTIN 5; PADGEM PROTEIN;

ADULT; ARTICLE; BODY MASS; CHRONIC INFLAMMATION; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; FLOW CYTOMETRY; HUMAN; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOCYTE ACTIVATION; THROMBOCYTE COUNT; ANALYSIS OF VARIANCE; BLOOD; CROSS-SECTIONAL STUDY; METABOLISM; MIDDLE AGED;

ADULT; ANALYSIS OF VARIANCE; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; FEMALE; FLOW CYTOMETRY; HUMANS; MALE; MIDDLE AGED; OBESITY; P-SELECTIN; PLATELET ACTIVATION; PLATELET COUNT;

EID: 43849092981     PISSN: 09629351     EISSN: 14661861     Source Type: Journal    
DOI: 10.1155/2008/834153     Document Type: Article

References (32)

1. Baatout S., Interleukin-6 and megakaryocytopoiesis: an update Annals of Hematology 1996 73 4 157 162
2. Carter A. J., Hanley S. P., The effect of platelet number and haematocrit on whole blood thromboxane synthesis Thrombosis and Haemostasis 1985 53 2 225 227
3. Chobanian A. V., Bakris G. L., Black H. R., The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report Journal of the American Medical Association 2003 289 19 2560 2572
4. Collins C. E., Rampton D. S., Review article: platelets in inflammatory bowel disease - pathogenetic role and therapeutic implications Alimentary Pharmacology & Therapeutics 1997 11 2 237 247
5. Davi G., Guagnano M. T., Ciabattoni G., Platelet activation in obese women: role of inflammation and oxidant stress Journal of the American Medical Association 2002 288 16 2008 2014
6. De Pergola G., Pannacciulli N., Coviello M., sP-selectin plasma levels in obesity: association with insulin resistance and related metabolic and prothrombotic factors. Nutrition, Metabolism and Cardiovascular Diseases. In press
7. Dogru T.
8. Douglas J. T., Lowe G. D. O., Forbes C. D., Prentice C. R. M., β -thromboglobulin and platelet counts-effect of malignancy, infection, age and obesity Thrombosis Research 1982 25 6 459 464
9. Eckel R. H., Krauss R. M., American Heart Association call to action: obesity as a major risk factor for coronary heart disease Circulation 1998 97 21 2099 2100
10. Fabris F., Randi M. L., Casonato A., Dal Bo Zanon R., Bonvicini P., Girolami A., Clinical significance of β -thromboglobulin in patients with high platelet count Acta Haematologica 1984 71 1 32 38
11. Green M. S., Peled I., Najenson T., Gender differences in platelet count and its association with cigarette smoking in a large cohort in Israel Journal of Clinical Epidemiology 1992 45 1 77 84
12. Grundy S. M., Brewer H. B. Jr., Cleeman J. I., Smith S. C. Jr., Lenfant C., Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition Circulation 2004 109 3 433 438
13. Konstantinides S., Schäfer K., Koschnick S., Loskutoff D. J.
14. Lazzari L.
15. Licata G., Scaglione R., Giammarresi C., Davi G., No evidence of platelet activation in obesity Thrombosis and Haemostasis 1993 70 3 544
16. Ly H. Q., Kirtane A. J., Murphy S. A., Association of platelet counts on presentation of clinical outcomes in ST-elevation myocardial infarction American Journal of Cardiology 2006 98 1 1 5
17. Marquardt L., Ruf A., Mansmann U., Course of platelet activation markers after ischemic stroke Stroke 2002 33 11 2570 2574
18. McCabe D. J. H.
19. Meade T. W., Vickers M. V., Thompson S. G., Stirling Y., Haines A. P., Miller G. J., Epidemiological characteristics of platelet aggregability British Medical Journal 1985 290 6466 428 432
20. Michiels J. J.
21. Nakata M., Yada T., Soejima N., Maruyama I.
22. Nieman D. C., Henson D. A., Nehlsen-Cannarella S. L., Influence of obesity on immune function Journal of the American Dietetic Association 1999 99 3 294 299
23. Nieto F. J., Szklo M., Folsom A. R., Rock R., Mercuri M., Leukocyte count correlates in middle-aged adults: the atherosclerosis risk in communities (ARIC) study American Journal of Epidemiology 1992 136 5 525 537
24. Rifai N.
25. Scharf R. E., Tomer A., Marzec U. M., Teirstein P. S., Ruggeri Z. M., Harker L. A., Activation of platelets in blood perfusing angioplasty-damaged coronary arteries. Flow cytometric detection Arteriosclerosis and Thrombosis 1992 12 12 1475 1487
26. Tangorra A., Ferretti G., Curatola G., Altered properties of platelet membrane in childhood obesity Biochemistry International 1988 17 5 837 846
27. Tomer A., Harker L. A., Kasey S., Eckman J. R., Thrombogenesis in sickle cell disease Journal of Laboratory and Clinical Medicine 2001 137 6 398 407
28. Tomer A., Kasey S., Connor W. E., Clark S., Harker L. A., Eckman J. R., Reduction of pain episodes and prothrombotic activity in sickle cell disease by dietary n-3 fatty acids Thrombosis and Haemostasis 2001 85 6 966 974
29. Visser M.
30. Williams J. L., Pipia G. G., Datta N. S., Long M. W., Thrombopoietin requires additional megakaryocyte-active cytokines for optimal ex vivo expansion of megakaryocyte precursor cells Blood 1998 91 11 4118 4126
31. Yudkin J. S.
32. Yudkin J. S.